Cardio Diagnostics Holdings, Inc. (CDIO) NASDAQ

4.15

-0.14(-3.26%)

Updated at July 11 04:00PM

Currency In USD

Cardio Diagnostics Holdings, Inc.

Address

400 N Aberdeen St

Chicago, IL 60642

United States of America

Phone

855 226 9991

Sector

Healthcare

Industry

Biotechnology

Employees

13

First IPO Date

January 14, 2022

Key Executives

NameTitlePayYear Born
Dr. Meeshanthini V. Dogan Ph.D.Co-Founder, Chief Executive Officer & Director311,0001989
Mr. Timur Dogan Ph.D.Chief Technology Officer259,1671989
Ms. Elisa Michael Luqman Esq., J.D., M.B.A.Chief Financial Officer & Principal Accounting Officer275,0001964
Ms. Khullani Abdullahi J.D.Vice President of Revenue & Strategy01984
Dr. Robert A. Philibert M.D., Ph.D.Co-Founder, Chief Medical Officer & Director01962

Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.